Department of Urology, Ercieys University, Faculty Of Medicine,
Kayseri, 38039, Turkey (Türkiye)
NCT Number: NCT03936673
Urinary tract obstruction is a serious health problem due to kidney damage. Relative renal function has an important role in the treatment of obstructed kidneys. Nephrectomy can be recommended when the relative renal function is 10% or less in radionuclide examinations. Recently, however, nephron sparing approaches have come to the fore. This indicated the need to evaluate the possibility of recovering the function of the kidney before nephrectomy. The aim of this study is to compare relative functions of obstructed kidneys in technetium 99m dimercaptosuccinic acid scintigraphy (DMSA) before and 2 weeks after nephrostomy tube.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Kayseri, 38039, Turkey (Türkiye)
Obstructive uropathy is one of the most important causes of acute renal injury and end-stage renal failure. obstruction of urine flow increases the intratubular pressure. This pressure increase causes decrease in renal blood flow and starts the inflammatory process. In the first few hours after total ureter obstruction, due to the increase in intratubular pressure glomerular filtration ceases and tubular transport is markedly decreased. Long lasting obstruction results in renal fibrosis and end stage renal damage. Basically obstructive uropathy leading to irreversible renal damage and loss of renal function is the main indication for simple nephrectomy. Serious renal parenchymal damage is defined as non-functioning kidney having relative renal function (RRF) 10% or less in the literature. But recently in some studies it was suggested that by applying the nephrostomy catheter, ability of kidney to regain function can be evaluated before nephrectomy. So, possibility of gaining function should be kept in mind. In this study effect of percutaneous nephrostomy tube on serum creatinine, blood urea nitrogen (BUN) and RRF in obstructed kidney with RRF 10% or less. Before and 2 weeks after percutaneous nephrostomy, serum creatinine, ure and RRF in DMSA was recorded and compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 weeks after nephrostomy
serum creatinine level 2 weeks after nephrostomy
Time frame: 2 weeks after nephrostomy
Serum BUN level 2 weeks after nephrostomy
Time frame: 2 weeks after nephrostomy
RRF in DMSA 2 weeks after nephrostomy
TC Erciyes University
Other
The Effect of Percutaneous Nephrostomy Application on Obstructed Kidneys With Relative Function of 10% or Less In Technetium-99m Dimercaptosuccinic Acid (DMSA) Scintigraphy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02138877
Multicystic renal dysplasia, bilateral, Neonatal Hydronephrosis
Cairo, Egypt
View Trial DetailsNCT02055430
Acute Kidney Injury, Acute Renal Failure
Cairo, Egypt
View Trial DetailsNCT07627880
Acute Kidney Injury, Calculous Anuria
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT07617948
Acute Calculous Anuria, Acute Kidney Injury
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial Details